Navigation Links
Oramed Pharmaceuticals Announces Successful Results of a Novel Exploratory Clinical Study of its Flagship Oral Insulin Capsule
Date:9/14/2010

printinclude-->

Oramed Pharmaceuticals Announces Successful Results of a Novel Exploratory Clinical Study of its Flagship Oral Insulin Capsule

   

Proof of Concept Study for a New Indication of Oral Insulin Capsule for Type 1 Diabetics

JERUSALEM, September 14, 2010 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) announced today successful results in an exploratory clinical trial testing the effectiveness of its oral insulin capsule (ORMD-0801) in Type I diabetes patients suffering from uncontrolled diabetes.

In parallel to Oramed's main focus in developing an oral insulin capsule for management of Type II diabetes the company is exploring an application of its oral insulin capsule toward cases of uncontrolled Type I diabetics. Unstable or labile diabetes is characterized by recurrent, unpredictable and dramatic blood glucose swings often linked with irregular hyperglycemia and sometimes serious hypoglycemia affecting Type I diabetes patients. This newly completed exploratory study was a proof of concept study for defining a novel indication for ORMD-0801. The encouraging results justify further clinical development of ORMD-0801 capsule application toward management of uncontrolled diabetes.

"This study marks an impressive milestone for Oramed," says Nadav Kidron, CEO of Oramed Pharmaceuticals. "These results suggest a possible novel and unique indication for our oral insulin product in the treatment of Type I diabetes in addition to our main indication for Type II diabetes."

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in Phase 2 clinical trials.
'/>"/>

SOURCE Oramed Pharmaceticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Orameds Oral Insulin Capsules
2. Oramed Pharmaceuticals to Present at the 70th Scientific Sessions of the American Diabetes Association
3. Oramed Pharmaceuticals Forms Joint Venture - Launches Entera Bio Ltd.
4. Oramed Pharmaceuticals Expands Scientific Advisory Board With the Appointment of John Amatruda, M.D.
5. Oramed Pharmaceuticals Announces Filing of Two Registration Statements
6. Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Societys Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA)
7. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the 2009 British Pharmaceutical Conference in Manchester, England
8. Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009
9. Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule
10. Oramed Pharmaceuticals to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the ADA (June 5-9, New Orleans, LA)
11. Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015 /CNW/ - Covalon Technologies Ltd. ... technologies company, today announced financial results for its first ... the three months ended December 31, 2014, revenue was ... quarter was $229,820 or $0.02 per share.  ... said "I am very pleased with the significant progress ...
(Date:2/27/2015)... 2015  Organovo Holdings, Inc. (NYSE MKT: ONVO) ... breakthrough 3D bioprinting technology, announced today that ... will present live at VirtualInvestorConferences.com on March 5th. ... us for this Company update," said Mr. Murphy. ... launch of the exVive3D Liver, Bioprinted Human Tissue, ...
(Date:2/27/2015)... MINNEAPOLIS , Feb. 27, 2015  Uroplasty, Inc. (NASDAQ: ... develops, manufactures and markets innovative proprietary products to treat ... the 27th Annual ROTH Conference on Tuesday, March 10, ... Brett Reynolds , Chief Financial Officer, will present ... one on one at the conference at the Ritz ...
Breaking Medicine Technology:Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 2Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 4Uroplasty to Participate in the 27th Annual ROTH Conference 2
... announces that a new market research report is ... Pharmaceuticals: Global Industry Almanac ... Industry Almanac: Global Industry Almanac is an essential ... OTC Pharmaceuticals industry. It includes detailed data on ...
... 2011 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ("Simcere" or ... leading pharmaceutical company specializing in the development, manufacturing, ... China, today announced the resignation of chief financial ... January 15, 2011. Simcere,s Board of Directors has ...
Cached Medicine Technology:Reportlinker Adds OTC Pharmaceuticals: Global Industry Almanac 2Reportlinker Adds OTC Pharmaceuticals: Global Industry Almanac 3Simcere Pharmaceutical Group Announces Resignation of CFO Frank Zhao 2
(Date:2/28/2015)... IL (PRWEB) February 28, 2015 With ... Chunk Fitness has added an additional exercise to their ... the oblique exercise is most commonly known as, is ... , “Rope Pulls” are executed in a relatively safe ... fitness and strength levels. The full description of “Rope ...
(Date:2/28/2015)... Vancouver personal injury lawyers at Jiwa Law Corporation recently announced ... They stated that in many cases, missing an important time ... Many a time, delays in making an injury claim can ... As a result, experts at Jiwa Law Corporation suggest that ... injury lawyer in order to know more about their rights. ...
(Date:2/28/2015)... February 28, 2015 Pioneer Millworks reclaimed ... Japan Architecture & Construction Materials Show, an annual, premier ... than 1,000 suppliers and top manufacturers of the latest ... wood products sourced and manufactured by Pioneer Millworks ... popularity in Japan at restaurants, hotels, retailers, and corporate ...
(Date:2/28/2015)... Kaylie Corrigan, Outdoor Supervisor at Back2Basics Outdoor ... student obtaining her Masters degree in social work at ... psychoeducation on substance use for teens at the local ... her studies. , “Even though these students are young, ... the high school and junior high school level,” said ...
(Date:2/28/2015)... California (PRWEB) February 28, 2015 Developers of ... release of a new overlay plugin for Final Cut Pro ... Studios. , “FCPX Overlay Chromatic gives users total control over ... Christina Austin, CEO of Pixel Film Studios. “FCPX Overlay Chromatic ... an easy to use interface.” , FCPX Overlay Chromatic Grunge ...
Breaking Medicine News(10 mins):Health News:Jiwa Law Corporation Recently Announced That Time Delays May Weaken Personal Injury Claims 2Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2Health News:Staff at Arizona Drug Addiction Treatment Center Starts Teen Sobriety Support Group at Local High School 2Health News:Pixel Film Studios released a new overlay plugin entitled FCPX Overlay Chromatic Grunge 6K exclusively for Final Cut Pro X users 2
... Quarter Driven by Improved Margins and Higher Sales of ... Pharmaceutical Companies, Inc. (NYSE: PRX ) today ... 2009. Par reported total revenues of $204.0 million and ... share, which included a change in estimate relating to ...
... President Obama,s advice to exercise prudence, but not to ... According to Global Distribution System and Online Travel ... and leisure travel continues, despite a decline to Mexico ... very few cancellations outside of Mexico. Many are ...
... 6 AMN Healthcare Services, Inc. (NYSE: AHS ), ... presentation on Tuesday, May 12, 2009 at 2:40 p.m. Eastern Time ... Conference taking place at the Palace Hotel in New York City, ... at the Robert W. Baird 2009 Growth Stock Conference taking place ...
... Dr. Jan Linhart and wife Ellen honored for generous contribution to ... ... May 6, 2009 -- Dr. Jan Linhart, D.D.S. and his wife, ... Linhart Continuing Dental Education Program at Dr. Linhart’s alma mater. In ...
... the New York tri-state premier monthly magazine for ... will honor its 40 Under Forty achievement award ... annual awards dinner, will be hosted by Shon ... D. Pinkett, Ph.d., co-founder, chairman and CEO of ...
... Calif., May 5 In a year of ... largest union and professional association of registered nurses, ... Committee have endorsed the direction of the organization ... and other incumbent members of the CNA/NNOC Board ...
Cached Medicine News:Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 2Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 3Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 4Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 5Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 6Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 7Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 8Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 9Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 10Health News:Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009 11Health News:AMN Healthcare Services to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference and at the Robert W. Baird 2009 Growth Stock Conference 2Health News:Manhattan Dentist Inducted Into The Sir Harold Acton Society 2Health News:The Network Journal Announces its 2009 List of "40 Under Forty" Dynamic Achievers 2Health News:The Network Journal Announces its 2009 List of "40 Under Forty" Dynamic Achievers 3Health News:The Network Journal Announces its 2009 List of "40 Under Forty" Dynamic Achievers 4Health News:The Network Journal Announces its 2009 List of "40 Under Forty" Dynamic Achievers 5Health News:CNA/NNOC Re-Elects Council of Presidents 2
Biosite continues its tradition of leadership and innovation with the development of the Triage TOX Drug Screen. This breakthrough technology sets new standards for clear, convenient and controlled,...
... Advanced Model 3900 Multi-Sample Osmometer is ... processing moderate to high volumes of ... of freezing-point technology for an accurate ... high, continuous throughput, the Advanced Instruments ...
... Micro-Osmometer is an automated, single-sample osmometer, designed ... 3320 is ideally suited for clinical and ... Model 3320 employs the industry preferred freezing-point ... robust and dependable throughout fifty years of ...
... The Advanced® 2020 Multi-Sample Osmometer ... clinical, industrial, and research settings. These ... industry-preferred freezing-point method, which determines total ... offers on-board data management, automated sample ...
Medicine Products: